Literature DB >> 28373420

Y-box Binding Protein 1 Is Involved in Regulating the G2/M Phase of the Cell Cycle.

Yojiro Kotake1,2, Nagisa Arikawa3, Keiichiro Tahara3, Hiroaki Maru2, Madoka Naemura3.   

Abstract

BACKGROUND/AIM: The transcription factor Y-box-binding protein 1 (YB1) is overexpressed in many types of human cancers. YB1 regulates the G1 phase of the cell cycle by controlling transcription of G1 regulators. Here, we report that YB1 is also involved in regulating G2/M phase.
MATERIALS AND METHODS: YB1-depleted TKO cells were subjected to quantitative reverse transcription-polymerase chain reaction and cell-cycle analysis. RNA immunoprecipitation (RIP)-chip assay was performed using anti-YB1 antibodies. Precipitated RNAs were subjected to microarray analysis.
RESULTS: Silencing YB1 inhibited the proliferation of TKO cells, which lost the machinery required for G1 phase arrest. Cell-cycle analysis showed that silencing YB1 caused G2/M phase cell-cycle arrest. RIP-chip assay showed that YB1 associated with mRNA of multiple cell-cycle-related genes, including G2/M phase regulators.
CONCLUSION: YB1 positively regulates not only the G1 phase but also G2/M phase by regulating multiple cell-cycle-related genes. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Oncogene; YB1; cell cycle; p16; pRB

Mesh:

Substances:

Year:  2017        PMID: 28373420     DOI: 10.21873/anticanres.11490

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Cell cycle gene regulation dynamics revealed by RNA velocity and deep-learning.

Authors:  Andrea Riba; Attila Oravecz; Matej Durik; Sara Jiménez; Violaine Alunni; Marie Cerciat; Matthieu Jung; Céline Keime; William M Keyes; Nacho Molina
Journal:  Nat Commun       Date:  2022-05-23       Impact factor: 17.694

2.  RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells via binding to AURKA mRNA.

Authors:  Yuanyuan Ban; Yixin Tan; Xiaoling Li; Xiayu Li; Zhaoyang Zeng; Wei Xiong; Guiyuan Li; Bo Xiang; Mei Yi
Journal:  J Cancer       Date:  2021-04-07       Impact factor: 4.207

3.  YB-1 Is Altered in Pregnancy-Associated Disorders and Affects Trophoblast in Vitro Properties via Alternation of Multiple Molecular Traits.

Authors:  Violeta Stojanovska; Aneri Shah; Katja Woidacki; Florence Fischer; Mario Bauer; Jonathan A Lindquist; Peter R Mertens; Ana C Zenclussen
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

4.  miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.

Authors:  Zhuojia Lin; Yanan Lu; Qiuyu Meng; Chen Wang; Xiaonan Li; Yuxin Yang; Xiaoru Xin; Qidi Zheng; Jie Xu; Xin Gui; Tianming Li; Hu Pu; Wujun Xiong; Jiao Li; Song Jia; Dongdong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-12       Impact factor: 8.886

5.  Dephosphorylation of YB-1 is Required for Nuclear Localisation During G2 Phase of the Cell Cycle.

Authors:  Sunali Mehta; Cushla McKinney; Michael Algie; Chandra S Verma; Srinivasaraghavan Kannan; Rhodri Harfoot; Tara K Bartolec; Puja Bhatia; Alistair J Fisher; Maree L Gould; Kim Parker; Anthony J Cesare; Heather E Cunliffe; Scott B Cohen; Torsten Kleffmann; Antony W Braithwaite; Adele G Woolley
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

6.  Long Non-coding RNA Aerrie Controls DNA Damage Repair via YBX1 to Maintain Endothelial Cell Function.

Authors:  Tan Phát Pham; Diewertje I Bink; Laura Stanicek; Anke van Bergen; Esmee van Leeuwen; Yvonne Tran; Ljubica Matic; Ulf Hedin; Ilka Wittig; Stefanie Dimmeler; Reinier A Boon
Journal:  Front Cell Dev Biol       Date:  2021-01-11

Review 7.  Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.

Authors:  Wing-Kee Lee; Thévenod Frank
Journal:  Cancer Drug Resist       Date:  2021-06-19

8.  YBX1 promotes tumor progression via the PI3K/AKT signaling pathway in laryngeal squamous cell carcinoma.

Authors:  Jing Zhao; Pu Zhang; Xin Wang
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.